An Irish Observational Study to Evaluate LUTS Storage Symptom Improvement in Men Being Treated With Vesitirim(R) (Solifenacin)

Trial Profile

An Irish Observational Study to Evaluate LUTS Storage Symptom Improvement in Men Being Treated With Vesitirim(R) (Solifenacin)

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Jan 2013

At a glance

  • Drugs Solifenacin (Primary)
  • Indications Lower urinary tract symptoms
  • Focus Therapeutic Use
  • Acronyms VIM
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 01 Dec 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Jul 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top